A Phase I/II Trial Evaluating the Use of Histone Deacetylase Inhibitor LBH589 in Addition to Corticosteroids in Patients With Acute Graft Versus Host Disease
Phase of Trial: Phase I/II
Latest Information Update: 28 Mar 2017
At a glance
- Drugs Panobinostat (Primary)
- Indications Graft-versus-host disease
- Focus Adverse reactions; Therapeutic Use
- 27 Oct 2016 Status changed from active, no longer recruiting to completed.
- 25 Apr 2016 Planned End Date changed from 1 Jun 2016 to 1 Nov 2016.
- 25 Apr 2016 Planned primary completion date changed from 1 Jun 2016 to 1 Nov 2016.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History